NRS 453.219 Controlled substance analog: Treatment as substance in schedule I; notice of prosecution; determination by Board.
120 words·~1 min read·
/nv/chapter-453-controlled-substances/453-219A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
NRS 453.219 Controlled substance analog: Treatment as substance in schedule I; notice of prosecution; determination by Board. A controlled substance analog, to the extent intended for human consumption, must be treated, for the purposes of NRS 453.011 to 453.552 , inclusive, as a substance included in schedule I. Within 30 days after the initiation of prosecution with respect to a controlled substance analog by indictment or information, the district attorney shall notify the Board of information relevant to scheduling by extraordinary regulation as provided for in NRS 453.2184 .
If the Board finally determines that the controlled substance analog should not be scheduled, no prosecution relating to that substance as a controlled substance analog may be commenced or continued.
Regulations